These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 35327540)

  • 1. Glucose- and Non-Glucose-Induced Mitochondrial Dysfunction in Diabetic Kidney Disease.
    Ito M; Gurumani MZ; Merscher S; Fornoni A
    Biomolecules; 2022 Feb; 12(3):. PubMed ID: 35327540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glomerular Endothelial Mitochondrial Dysfunction Is Essential and Characteristic of Diabetic Kidney Disease Susceptibility.
    Qi H; Casalena G; Shi S; Yu L; Ebefors K; Sun Y; Zhang W; D'Agati V; Schlondorff D; Haraldsson B; Böttinger E; Daehn I
    Diabetes; 2017 Mar; 66(3):763-778. PubMed ID: 27899487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial dysfunction in diabetic tubulopathy.
    Yao L; Liang X; Qiao Y; Chen B; Wang P; Liu Z
    Metabolism; 2022 Jun; 131():155195. PubMed ID: 35358497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial Contribution to Inflammation in Diabetic Kidney Disease.
    Mitrofanova A; Fontanella AM; Burke GW; Merscher S; Fornoni A
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial dysfunction in diabetic kidney disease.
    Wei PZ; Szeto CC
    Clin Chim Acta; 2019 Sep; 496():108-116. PubMed ID: 31276635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction.
    Qi W; Keenan HA; Li Q; Ishikado A; Kannt A; Sadowski T; Yorek MA; Wu IH; Lockhart S; Coppey LJ; Pfenninger A; Liew CW; Qiang G; Burkart AM; Hastings S; Pober D; Cahill C; Niewczas MA; Israelsen WJ; Tinsley L; Stillman IE; Amenta PS; Feener EP; Vander Heiden MG; Stanton RC; King GL
    Nat Med; 2017 Jun; 23(6):753-762. PubMed ID: 28436957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial Dysfunction in Individuals with Diabetic Kidney Disease: A Systematic Review.
    Flemming N; Pernoud L; Forbes J; Gallo L
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DsbA-L deficiency exacerbates mitochondrial dysfunction of tubular cells in diabetic kidney disease.
    Gao P; Yang M; Chen X; Xiong S; Liu J; Sun L
    Clin Sci (Lond); 2020 Apr; 134(7):677-694. PubMed ID: 32167139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Glucose Metabolism and Mitochondrial Function in Diabetic Kidney Disease.
    Stanton RC
    Curr Diab Rep; 2021 Jan; 21(2):6. PubMed ID: 33449215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NADH/NAD
    Yan LJ
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34068842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Mitochondria-Targeted Metabolic Tubular Injury in Diabetic Kidney Disease.
    Jiang H; Shao X; Jia S; Qu L; Weng C; Shen X; Wang Y; Huang H; Wang Y; Wang C; Feng S; Wang M; Feng H; Geekiyanage S; Davidson AJ; Chen J
    Cell Physiol Biochem; 2019; 52(2):156-171. PubMed ID: 30816665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose and Blood Pressure-Dependent Pathways-The Progression of Diabetic Kidney Disease.
    Patel DM; Bose M; Cooper ME
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Might hyperbaric oxygen therapy (HBOT) reduce renal injury in diabetic people with diabetes mellitus? From preclinical models to human metabolomics.
    Harrison LE; Giardina C; Hightower LE; Anderson C; Perdrizet GA
    Cell Stress Chaperones; 2018 Nov; 23(6):1143-1152. PubMed ID: 30374882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress as a culprit in diabetic kidney disease.
    Su S; Ma Z; Wu H; Xu Z; Yi H
    Life Sci; 2023 Jun; 322():121661. PubMed ID: 37028547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Warburg Effect in Diabetic Kidney Disease.
    Zhang G; Darshi M; Sharma K
    Semin Nephrol; 2018 Mar; 38(2):111-120. PubMed ID: 29602394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine protects against diabetic kidney disease via promoting PGC-1α-regulated mitochondrial energy homeostasis.
    Qin X; Jiang M; Zhao Y; Gong J; Su H; Yuan F; Fang K; Yuan X; Yu X; Dong H; Lu F
    Br J Pharmacol; 2020 Aug; 177(16):3646-3661. PubMed ID: 31734944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing Metabolomics to Describe the Pathophysiology Underlying Progression in Diabetic Kidney Disease.
    Hasegawa S; Inagi R
    Curr Diab Rep; 2021 May; 21(7):21. PubMed ID: 33974145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial dynamics and diabetic kidney disease: Missing pieces for the puzzle of therapeutic approaches.
    Narongkiatikhun P; Chattipakorn SC; Chattipakorn N
    J Cell Mol Med; 2022 Jan; 26(2):249-273. PubMed ID: 34889040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AKAP1 contributes to impaired mtDNA replication and mitochondrial dysfunction in podocytes of diabetic kidney disease.
    Feng J; Chen Z; Ma Y; Yang X; Zhu Z; Zhang Z; Hu J; Liang W; Ding G
    Int J Biol Sci; 2022; 18(10):4026-4042. PubMed ID: 35844803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Necrosis Factor Receptor-Associated Protein 1 Protects against Mitochondrial Injury by Preventing High Glucose-Induced mPTP Opening in Diabetes.
    Liu L; Zhang L; Zhao J; Guo X; Luo Y; Hu W; Zhao T
    Oxid Med Cell Longev; 2020; 2020():6431517. PubMed ID: 32215175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.